Oppenheimer Increases Addus HomeCare (NASDAQ:ADUS) Price Target to $140.00

Addus HomeCare (NASDAQ:ADUS) had its price objective boosted by Oppenheimer from $130.00 to $140.00 in a research report sent to investors on Wednesday morning, Benzinga reports. They currently have an outperform rating on the stock.

Other equities research analysts have also issued research reports about the stock. Bank of America upped their target price on shares of Addus HomeCare from $115.00 to $118.00 and gave the company a buy rating in a research note on Tuesday, May 7th. Stephens reiterated an overweight rating and issued a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday. StockNews.com lowered Addus HomeCare from a strong-buy rating to a buy rating in a research report on Sunday, July 7th. TD Cowen lifted their price objective on shares of Addus HomeCare from $119.00 to $128.00 and gave the stock a buy rating in a report on Tuesday, June 18th. Finally, Macquarie started coverage on shares of Addus HomeCare in a report on Friday, June 28th. They set an outperform rating and a $136.00 target price on the stock. One research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of Moderate Buy and a consensus price target of $127.57.

Addus HomeCare Stock Up 0.1 %

Addus HomeCare stock traded up $0.16 during midday trading on Wednesday, hitting $124.63. 73,363 shares of the stock were exchanged, compared to its average volume of 136,526. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.35 and a quick ratio of 1.35. The company has a 50 day moving average price of $119.11 and a two-hundred day moving average price of $105.77. The firm has a market cap of $2.26 billion, a P/E ratio of 30.93, a P/E/G ratio of 2.35 and a beta of 1.01. Addus HomeCare has a 1 year low of $78.35 and a 1 year high of $126.70.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million during the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.94 earnings per share. On average, sell-side analysts predict that Addus HomeCare will post 4.36 earnings per share for the current fiscal year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the firm’s stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at $1,186,500.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its position in Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares during the period. American Century Companies Inc. lifted its holdings in shares of Addus HomeCare by 90.6% in the second quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock valued at $2,136,000 after buying an additional 8,743 shares during the period. Van Hulzen Asset Management LLC boosted its stake in Addus HomeCare by 5.4% during the second quarter. Van Hulzen Asset Management LLC now owns 30,175 shares of the company’s stock valued at $3,504,000 after buying an additional 1,551 shares in the last quarter. Texas Permanent School Fund Corp boosted its stake in Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after buying an additional 82 shares in the last quarter. Finally, Choreo LLC acquired a new position in Addus HomeCare during the second quarter worth about $340,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.